PTGS2 and breast carcinoma: Moreover, in settings such as MUC1−C–activated triple−negative breast cancer, the IFN−γ–driven JAK1→STAT1→IRF1 pathway leads to the induction of immunosuppressive effectors like IDO1 and COX2/PTGS2 (27).